The Fas signalling pathway and its role in the pathogenesis of cancer

Current Opinion in Pharmacology
Aileen M Houston, Joe O'Connell

Abstract

Tumor cells frequently exhibit de novo expression of Fas ligand (FasL/CD95L). Coupled with resistance to Fas-mediated apoptosis, FasL expression enables many cancers to deliver a pre-emptive strike or 'counterattack' against the immune system. New studies also indicate that FasL expression on tumor cells could confer a double advantage to these cells by stimulating their own proliferation. However, pro-inflammatory effects of FasL have also been observed. New findings are beginning to reconcile the paradoxical effects of FasL, with the clinical significance of the Fas counterattack only beginning to emerge.

Citations

Jan 26, 2006·Cancer Immunology, Immunotherapy : CII·Kerstin LangKurt S Zaenker
Apr 18, 2013·Archives of Dermatological Research·Göknur KalkanSaime Sezer
Jan 16, 2007·Apoptosis : an International Journal on Programmed Cell Death·Daniel SaganHedda Eichholtz-Wirth
Mar 11, 2006·Apoptosis : an International Journal on Programmed Cell Death·M LauricellaG Tesoriere
Jun 11, 2005·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Lisa Oliver, François M Vallette
Aug 11, 2005·Oncogene·Amanda J BaxendaleAristides G Eliopoulos
Aug 2, 2007·Prostate Cancer and Prostatic Diseases·L LimaR Medeiros
Mar 28, 2008·The Journal of Biological Chemistry·Camia SteinmannDarren Boehning
Oct 7, 2008·Journal of Toxicology and Environmental Health. Part a·Jose M MoranJose M Fuentes
Feb 3, 2007·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·Mazen Kurdi, George W Booz
May 26, 2011·Cell Communication and Signaling : CCS·Larissa KaufmannChristine Blattner
Jan 16, 2014·Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al]·E-M ThurnerT Langsenlehner
Apr 6, 2016·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Anjana Kumari NegiNavneet Agnihotri
May 12, 2009·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·T Schneider-MerckP Stärkel
Dec 17, 2008·Experimental Cell Research·Lili CaoWensheng Sun
Dec 25, 2007·Toxicology·Marilyn D SaulsburyDorothy Round
Oct 6, 2005·Journal of Cellular and Molecular Medicine·Nikolaus Seiler, Francis Raul
Aug 5, 2010·International Journal of Laboratory Hematology·D SaganOrathai Tangvarasittichai
Feb 8, 2013·International Journal of Cancer. Journal International Du Cancer·Grace O'CallaghanAileen Houston
Jun 12, 2013·Journal of Oral Pathology & Medicine : Official Publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology·Flavio de Alcântara CamejoPaula Cristina Trevilatto
Aug 2, 2005·Seminars in Cancer Biology·Burkhard BrandtThomas Dittmar
Jun 12, 2014·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Yeqiong XuWilliam C Cho
Jan 18, 2015·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Hongguang ZhaoLifang Wang
Mar 11, 2005·Expert Opinion on Therapeutic Targets·Andreas LinkermannOttmar Janssen
Aug 3, 2011·Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals·Guang-Bin ZhuXin-Chun Li
Jun 19, 2013·Journal of Receptor and Signal Transduction Research·Stylianos KykalosAnastasios Karayiannakis
Jul 18, 2012·Cancer Treatment Reviews·Lin-Tao JiaAn-Gang Yang
Dec 20, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Eric K Rowinsky
Jun 18, 2017·Expert Opinion on Therapeutic Patents·Guofeng HeShu Zhang
Jun 24, 2008·International Journal of Toxicology·Sinead LordanNora M O'Brien
Mar 16, 2018·Expert Review of Molecular Diagnostics·Dafina IlijaziShahrokh F Shariat
Jul 24, 2008·British Journal of Cancer·G O'CallaghanA Houston

❮ Previous
Next ❯

Related Concepts

Related Feeds

Caspases in Metabolic Diseases

Caspases, the family of cysteine proteases are involved in programmed cell death, but their role in metabolic diseases, inflammation and immunity has been of interested. Discover the latest research on caspases in metabolic diseases here.

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.

Breast Tumorigenesis

Breast tumorigenesis involves the production or formation of tumor(s) in breast tissue. Discover the latest research on breast tumorigenesis here.

Apoptotic Caspases

Apoptotic caspases belong to the protease enzyme family and are known to play an essential role in inflammation and programmed cell death. Here is the latest research.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Cancer Biology: Molecular Imaging

Molecular imaging enables noninvasive imaging of key molecules that are crucial to tumor biology. Discover the latest research in molecular imaging in cancer biology in this feed.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Related Papers

European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)
Yan LiuJian Zhang
The Journal of Pathology
Tineke TimmerSteven de Jong
International Journal of Cancer. Journal International Du Cancer
M MottoleseF M Venanzi
© 2022 Meta ULC. All rights reserved